8-KThe WireRoutine
Reg FD Disclosure
Filed Sep 10, 2024 · 1y ago · Accession 0001193125-24-216310
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Spero Therapeutics, Inc.
- Ticker
- SPRO
- CIK
- 1701108
- Form type
- 8-K
- Filing date
- Sep 10, 2024
- Report date
- Sep 9, 2024
- Document
- d819424d8k.htm
- Size
- 13.0 MB